205 related articles for article (PubMed ID: 33197567)
21. Repeatability of
Crandall JP; Fraum TJ; Lee M; Jiang L; Grigsby P; Wahl RL
J Nucl Med; 2021 May; 62(5):707-715. PubMed ID: 33008931
[TBL] [Abstract][Full Text] [Related]
22. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
van Velden FH; Kramer GM; Frings V; Nissen IA; Mulder ER; de Langen AJ; Hoekstra OS; Smit EF; Boellaard R
Mol Imaging Biol; 2016 Oct; 18(5):788-95. PubMed ID: 26920355
[TBL] [Abstract][Full Text] [Related]
23. An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer.
Lacoppidan T; Vogelius IR; Pøhl M; Strange M; Persson GF; Nygård L
Acta Oncol; 2019 Oct; 58(10):1386-1392. PubMed ID: 31271118
[No Abstract] [Full Text] [Related]
24. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Khorrami M; Jain P; Bera K; Alilou M; Thawani R; Patil P; Ahmad U; Murthy S; Stephans K; Fu P; Velcheti V; Madabhushi A
Lung Cancer; 2019 Sep; 135():1-9. PubMed ID: 31446979
[TBL] [Abstract][Full Text] [Related]
25. The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
Monaco L; De Bernardi E; Bono F; Cortinovis D; Crivellaro C; Elisei F; L'Imperio V; Landoni C; Mathoux G; Musarra M; Pagni F; Turolla EA; Messa C; Guerra L
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3401-3411. PubMed ID: 35403860
[TBL] [Abstract][Full Text] [Related]
26. Repeatability of
Pfaehler E; Beukinga RJ; de Jong JR; Slart RHJA; Slump CH; Dierckx RAJO; Boellaard R
Med Phys; 2019 Feb; 46(2):665-678. PubMed ID: 30506687
[TBL] [Abstract][Full Text] [Related]
27. Synergistic impact of motion and acquisition/reconstruction parameters on
Hosseini SA; Shiri I; Hajianfar G; Bahadorzadeh B; Ghafarian P; Zaidi H; Ay MR
Med Phys; 2022 Jun; 49(6):3783-3796. PubMed ID: 35338722
[TBL] [Abstract][Full Text] [Related]
28. Prognostic importance of
Kanyilmaz G; Benli Yavuz B; Aktan M; Sahin O
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):20-26. PubMed ID: 31668790
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and Predictive Values of Metabolic Parameters of
Li X; Wang D; Yu L
Mol Imaging; 2019; 18():1536012119846025. PubMed ID: 31144578
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ
Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X
Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646
[TBL] [Abstract][Full Text] [Related]
33. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
[TBL] [Abstract][Full Text] [Related]
34. Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
Kolinger GD; García DV; Kramer GM; Frings V; Zwezerijnen GJC; Smit EF; de Langen AJ; Buvat I; Boellaard R
J Nucl Med; 2022 Jun; 63(6):919-924. PubMed ID: 34933890
[TBL] [Abstract][Full Text] [Related]
35. Variability and Repeatability of Quantitative Uptake Metrics in
Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R
J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824
[TBL] [Abstract][Full Text] [Related]
36. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment
Satoh Y; Motosugi U; Saito A; Omiya Y; Onishi H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794934. PubMed ID: 30222060
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow and Tumor Radiomics at
Mattonen SA; Davidzon GA; Benson J; Leung ANC; Vasanawala M; Horng G; Shrager JB; Napel S; Nair VS
Radiology; 2019 Nov; 293(2):451-459. PubMed ID: 31526257
[TBL] [Abstract][Full Text] [Related]
40. Homological radiomics analysis for prognostic prediction in lung cancer patients.
Ninomiya K; Arimura H
Phys Med; 2020 Jan; 69():90-100. PubMed ID: 31855844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
